HIPAA-compliant infrastructure for genomics, personalized medicine, and clinical research. Audit-ready compliance + 15–25% cost optimization through managed FinOps.
Genomic sequencing, ML-driven drug discovery, personalized medicine. HIPAA-critical. Founders are biologists, not cloud architects.
Massive sequencing data + ML models + PHI (Protected Health Information). One compliance slip-up = catastrophic.
Encryption at rest/transit, audit logging, access controls, BAAs with all vendors. One misconfiguration = breach notification, fines, reputation damage.
Sequencing data = massive (terabytes). Storage + transfer costs spiral. ML models need fast access; data residency matters.
Training ML models on genomic data requires GPU clusters, frequent retraining. Cost-per-experiment tracking critical.
PHD scientists running research + company. Cloud ops = afterthought until bills shock them.
IRB (Institutional Review Boards), FDA (if clinical), investors all demand proof of controls + data protection.
Clinical trials, FDA submissions = time-sensitive. Infrastructure must scale on demand without breaking budget or compliance.
FinOps + HIPAA compliance automation + MLOps for genomics. Recurring retainer means auditors see clean, current controls.
Cost optimization + HIPAA automation bundled. 15–25% cost reduction + proof of compliance for IRB/FDA.
SageMaker pipelines for genomic prediction models, drug discovery ML, biomarker identification. HIPAA-compliant operations.
Monthly spend: $90K AWS (genomic sequencing + ML training).
Problem: No HIPAA documentation. Sequencing data stored "hot" in S3 = $30K/month waste. IRB audit in 3 months.
Identified $20K/month waste (data tiering opportunity). Built HIPAA-compliant architecture (encrypted storage, audit logs, access controls). Trained ops team on compliance framework.
New run-rate: $70K/month (22% reduction)
IRB audit ready in 6 weeks
Retainer: $10K/month (immediate ROI, ongoing compliance)
Investor pitch: "HIPAA-ready infrastructure, cost-efficient scaling"
HIPAA compliance assessment + cost optimization. IRB-ready reporting included.
Or send details below
Accelerate research with HIPAA-compliant AI. Genomic analysis, protein folding prediction, drug candidate screening, and clinical trial optimization—all within regulated environments.
Deep learning for variant calling, gene annotation, and personalized medicine.
AI-powered candidate screening and molecular property prediction.
Reduce fab and simulation costs while maintaining 99.99% uptime SLAs. Enterprise infrastructure for chip design.
Cut cost-per-transaction while staying SOX/PCI-DSS compliant. Compliance automation + cost optimization together.
Cut burn rate without slowing innovation. Energy and green hydrogen companies extend runway through FinOps.
Reduce infrastructure costs while maintaining carrier-grade 99.99%+ SLAs. Multi-region optimization at scale.
